124 related articles for article (PubMed ID: 28196051)
1. Technique for Infant Intravitreal Injection in Treatment of Retinopathy of Prematurity.
Wright LM; Vrcek IM; Scribbick FW; Chang EY; Harper CA
Retina; 2017 Nov; 37(11):2188-2190. PubMed ID: 28196051
[No Abstract] [Full Text] [Related]
2. What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?
Spandau U
Acta Ophthalmol; 2013 Mar; 91(2):e154. PubMed ID: 22989079
[No Abstract] [Full Text] [Related]
3. Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity.
Li XJ; Yang XP; Sun S; Lyu XB; Jia H
Chin Med J (Engl); 2016 Dec; 129(23):2879-2881. PubMed ID: 27901006
[No Abstract] [Full Text] [Related]
4. Globe size and bevacizumab treatment in retinopathy of prematurity: should we adjust the dose?
Connor AJ; Shafiq A
Eye (Lond); 2016 Nov; 30(11):1401-1403. PubMed ID: 27472209
[No Abstract] [Full Text] [Related]
5. Different refractive errors in triplets with retinopathy of prematurity treated with bevacizumab.
Tseng CC; Chen SN; Hwang JF; Lin CJ
J Pediatr Ophthalmol Strabismus; 2012 Aug; 49 Online():e41-3. PubMed ID: 22881829
[TBL] [Abstract][Full Text] [Related]
6. A new syringe adaptor for intravitreal injection of premature eye.
Kimura S; Tsukamoto M; Shiode Y; Hosogi M; Morizane Y
Retina; 2013 Apr; 33(4):889-90. PubMed ID: 23481457
[No Abstract] [Full Text] [Related]
7. Ultra-low dose of intravitreal bevacizumab in the treatment of retinopathy of prematurity.
Connor AJ; Papastavrou VT; Hillier RJ; Shafiq A
J Pediatr Ophthalmol Strabismus; 2015 Apr; 52 Online():e20-1. PubMed ID: 25942065
[TBL] [Abstract][Full Text] [Related]
8. Delayed-onset retinal detachment after an intravitreal injection of ranibizumab for zone 1 plus retinopathy of prematurity.
Jang SY; Choi KS; Lee SJ
J AAPOS; 2010 Oct; 14(5):457-9. PubMed ID: 21035077
[TBL] [Abstract][Full Text] [Related]
9. [Alarming use of anti-VEGF therapy in premature infants].
Hård AL; Hellström A
Lakartidningen; 2011 Dec 7-13; 108(49):2600. PubMed ID: 22468401
[No Abstract] [Full Text] [Related]
10. Occurrence of intraocular air bubbles during intravitreal injections for retinopathy of prematurity.
Sukgen EA; Gunay M; Kocluk Y
Int Ophthalmol; 2017 Feb; 37(1):215-219. PubMed ID: 27216852
[TBL] [Abstract][Full Text] [Related]
11. A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.
Yaz Y; Erol N; Gursoy H; Basmak H; Bilgec MD
J Pediatr Ophthalmol Strabismus; 2014 Oct; 51 Online():e66-8. PubMed ID: 25333243
[TBL] [Abstract][Full Text] [Related]
12. Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity.
Patel RD; Blair MP; Shapiro MJ; Lichtenstein SJ
Arch Ophthalmol; 2012 Jun; 130(6):801-2. PubMed ID: 22801851
[No Abstract] [Full Text] [Related]
13. Fluorescein angiography of aggressive posterior retinopathy of prematurity treated with intravitreal anti-VEGF in large preterm babies.
Park SW; Jung HH; Heo H
Acta Ophthalmol; 2014 Dec; 92(8):810-3. PubMed ID: 24909062
[No Abstract] [Full Text] [Related]
14. Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension.
Park L; Donohue L; Lakshminrusimha S; Sankaran D
J Perinatol; 2023 Feb; 43(2):236-237. PubMed ID: 35970854
[No Abstract] [Full Text] [Related]
15. A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.
Patel CK; Walker NJ; Kam JK
Br J Ophthalmol; 2010 Aug; 94(8):1107-9. PubMed ID: 20558426
[No Abstract] [Full Text] [Related]
16. Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.
Flavahan PW; Lavy TE; Wykes W
Scott Med J; 2013 Aug; 58(3):130-2. PubMed ID: 23960050
[TBL] [Abstract][Full Text] [Related]
17. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.
Kim J; Kim SJ; Chang YS; Park WS
Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
[TBL] [Abstract][Full Text] [Related]
19. Primary intravitreal ranibizumab for high-risk retinopathy of prematurity.
Baumal CR; Goldberg RA; Fein JG
Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):432-8. PubMed ID: 25970863
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China.
Feng J; Qian J; Jiang Y; Zhao M; Liang J; Yin H; Chen Y; Yu W; Li X
Ophthalmology; 2017 Mar; 124(3):408-409. PubMed ID: 27914833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
